Tenax Therapeutics announces reverse stock split
Tenax Therapeutics announced a reverse stock split of its shares of common stock at a ratio of 1-for-20. Beginning with the opening of trading on Monday, Feb. 26, 2018, the Company’s common stock will continue to trade on the Nasdaq Capital Market. February 23, 2018